Nucleoside incorporation into DNA and RNA in acute leukaemia: differences between the various leukaemia sub‐types

Publisher Website
Google Scholar
Abstract
The incorporation of the labeled deoxyribonucleosides 3H-deoxythymidine (3H-TdR), 3H-deoxycytidine (3H-CdR), 3H-deoxyadenosine (3H-AdR), 3H-deoxyguanosine (3H-GdR), 3H-deoxyuridine (3H-UdR) and of labeled uridine (3H-UR) into DNA and RNA was studied in bone marrow (BM) and peripheral blood (PB) cells from 10 normal donors and 11 patients with acute myeloblastic leukemia, 13 with acute non-T non-B common ALL (c-ALL) and 7 with thymic acute lymphoblastic leukemia. 3H-TdR incorporation was highest into the DNA of normal BM cells, 3H-CdR into DNA in Thy-ALL and 3H-UdR into DNA of c-ALL cells. Purine deoxynucleoside (3H-AdR and 3H-GdR) incorporation was highest in AML cells and they were incorporated mainly into RNA indicating that before utilization they are partially degraded from the deoxyribose to the corresponding ribose form. In all but 3 leukemia samples, the 3H-UdR/3H-TdR incorporation ratio was above the range found in normal bone marrow, suggesting that leukemic cells are more dependent than a normal mixed marrow cell population on the de novo pathway of thymidylate synthesis. The incorporation of nucleosides by peripheral blood cells was usually much lower than by the corresponding bone marrow cells, irrespective of blast percentage.